Advances in below-the-knee drug-eluting balloons

Journal of Cardiovascular Surgery

Volumn 53, Issue 2, 2012, Pages 205-213

  Ferraresi, R ^a   Centola, M ^b   Biondi Zoccai, G ^c  

^a ISTITUTO CLINICO CITTÀ STUDI   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Angioplasty; Limb salvage; Peripheral artery disease; Stents

Indexed keywords

IOPROMIDE; PACLITAXEL; ANTINEOPLASTIC AGENT;

ANGIOPLASTY; BREAST CANCER; CORONARY ARTERY DISEASE; DRUG DOSE TITRATION; DRUG ELUTING STENT; DRUG MECHANISM; HUMAN; LUNG CANCER; MEDICAL DEVICE; OVARY CANCER; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; REVIEW; INSTRUMENTATION; LEG; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSTHESIS; TREATMENT OUTCOME; VASCULARIZATION;

ANGIOPLASTY, BALLOON; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ARTERIAL OCCLUSIVE DISEASES; DRUG-ELUTING STENTS; HUMANS; LEG; PACLITAXEL; POPLITEAL ARTERY; PROSTHESIS DESIGN; TREATMENT OUTCOME;

EID: 84861797068     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology 1992;183:767-71.
2. Dormandy JA, Rutherford RB. Management of peripheral arterial disease. TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1-S296.
3. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL et al. American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006;47:1239-312.
4. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E 3rd, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007;33:S1-75.
5. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis. A special case of atherosclerosis progression. Circulation 1992;86:11147-52.
6. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-88.
7. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF et al. Patterns and mechanism of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996;94:1247-54. (Pubitemid 26307249)
8. Zimarino M, De Caterina R. Drug-eluting balloons for percutaneous coronary interventions. Thromb Haemos 2009;101:9-11
9. Biondi-Zoccai GG, Moretti C, Lotrionte M, Sheiban I. Safety of drug-coated stents. Expert Opin Drug Saf 2008;7:597-606.
10. Biondi-Zoccai GG, Sangiorgi G, Lotrionte M, Feiring A, Commeau P, Fusaro M et al. Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther 2009;16:251-60.
11. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the SFA: long-term results from the SIROCCO trial. J Endovasc Ther 2006;13:701-10. (Pubitemid 44907633)
12. Lammer J, Bosiers M, Zeller T, Schillinger M, Boone E, Zaugg MJ et al. First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. J Vasc Surg 2011;54:394-401.
13. Dake MD, Scheinen D, Tepe G, Tessarek J, Fanelli F, Bosiers M et al.; Zilver PTX Single-Arm Study Investigators. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther 2011;18:613-23.
14. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB et al.; Zilver PTX Investigators. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 2011;4:495-504.
15. Feiring AJ, Krahn M, Nelson L, Wesolowski A, Eastwood D, Szabo A. Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol 2010;55:1580-9.
16. Ferraresi R, Centola M, Ferlini M, Da Ros R, Caravaggi C, Assaloni R et al. Long-term outcomes after angioplasty of isolated, below-the-knee arteries in diabetic patients with critical limb ischaemia. Eur J Vasc Endovasc Surg 2009;37:336-42.
17. Abdelsalam H, Markose G, Bolia A. Revascularization strategies in below the knee interventions. J Cardiovasc Surg (Torino) 2008;49:187-91.
18. Graziani L, Silvestro A, Bertone V, Manara E, Andreini R, Sigala A et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg 2007;33:453-60. (Pubitemid 46349954)
19. Zeller T, Saratzis N, Scheinert D, Minar E, Beregi JP, Schillinger M et al. Non-randomized, prospective, multi-centre evaluation of the ABSOLUTE .035 peripheral self-expanding stent system for occluded or stenotic superficial femoral or proximal popliteal arteries (ASSESS Trial): acute and 30-day results. J Cardiovasc Surg (Torino) 2007;48:719-26. (Pubitemid 350268016)
20. Graziani L, Piaggesi A. Indications and clinical outcomes for below knee endovascular therapy: review article. Catheter Cardiovasc Interv 2010;75:433-43.
21. Schmidt A, Ulrich M, Winkler B, Klaeffling C, Bausback Y, Bräunlich S et al. Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease. Catheter Cardiovasc Interv 2010;76:1047-54.
22. Faglia E, Dalla Paola L, Clerici G, Clerissi J, Graziani L, Fusaro M et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003• Eur J Vasc Endovasc Surg 2005;29:620-7. (Pubitemid 40626707)
23. Scheinen D, Scheinen S, Sax J, Piorkowski C, Bräunlich S, Ulrich M et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-5. (Pubitemid 40094743)
24. Schlager O, Dick P, Sabeti S, Amighi J, Mlekusch W, Minar E et al. Long-segment SFA stenting - the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther 2005;12:676-84. (Pubitemid 43100925)
25. Marzullo R, Aprile A, Clementi F, Stella P, Modena MG, Sangiorgi GM. Paclitaxel eluting balloon: from bench to bedside. Minerva Cardioangiol 2009;57:597-609.
26. Sheiban I, Anselmino M, Moretti C, Biondi-Zoccai G, Galloni M, Vignolini C et al. Effect of a novel drug-eluted balloon coated with genistein before stent implantation in porcine coronary arteries. Clin Res Cardiol 2008;97:891-8.
27. Biondi-Zoccai GG, Sangiorgi G. Commentary: Below-the-knee/ankle revascularization: tools of the trade. J Endovasc Ther 2009;16:613-6.
28. Lavigne MC, Eppihimer MJ, Cheng R, Barry JJ. Anti-proliferative compounds for the prevention of restenosis. Curr Pharm Des 2010;16:3989-4001.
29. Axel DI, Kunert W, Göggelmann C, Oberhoff M, Herdeg C, Küttner A et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997;96:636-45. (Pubitemid 27329445)
30. Heldman AW, Cheng L, Jenkins GM, Heller PF, Kim DW, Ware M Jr et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 2001;103:2289-95. (Pubitemid 32433720)
31. Sangiorgi GM, Biondi-Zoccai GG, Agostoni P, Antoniucci D, Grube E, Di Mario C et al. Appraising the effectiveness and safety of paclitaxel-eluting stents in over 1,000 very high-risk patients: overall results of the Taxus in Real-life Usage Evaluation (TRUE) registry. Eurointervention 2007;3:333-9.
32. Dirksen MT, Vink MA, Suttorp MJ, Tijssen JG, Patterson MS, Slagboom T et al.; Paclitaxel-Eluting Stent versus Conventional Stent; in Myocardial Infarction with ST-Segment Elevation (PASSION) investigators. Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study. Eurointervention 2008;4:64-70.
33. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U et al. Treatment of coronary in-stent restenosis with a paclitaxel coated balloon catheter. N Engl J Med 2006;355:2113-24. (Pubitemid 44749319)
34. Herdeg C, Goehring-Frischholz K, Zuern C, Geisler T, Hartmann U, Hoevelborn T et al. Local catheter-based delivery of antithrombotic or antiproliferative drugs: a new concept for prevention of restenosis. Thromb Res 2008;123:236-43.
35. Herdeg C, Göhring-Frischholz K, Haase KK, Geisler T, Zürn C, Hartmann U et al. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation. Circ Cardiovasc Intervent 2009;2:294-301.
36. Camenzind E. Treatment of in-stent restenosis - back to the future? N Engl J Med 2006;355:2149-51. (Pubitemid 44749325)
37. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2008;97:773-81.
38. Unverdorben M, Kleber FX, Heuer H, Figulla HR, Vallbracht C, Leschke M et al. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2010;99:165-74.
39. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary instent restenosis. Circulation 2009;119:2986-94.
40. Fanggiday JC, Stella PR, Guyomi SH, Doevendans PA. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry. Catheter Cardiovasc Interv 2008;71:629-35. (Pubitemid 351559549)
41. Cortese B. Paclitaxel-eluting balloon versus paclitaxel-eluting stent in small coronary vessel disease. The Piccoleto trial. Presented at EuroPCR; May 21, 2009 Barcelona, Spain.
42. Tepe G, Schmitmeier S, Speck U, Schnorr B, Kelsch B, Scheller B. Advances on drug-coated balloons. J Cardiovasc Surg (Torino) 2010;51:125-43.
43. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwälder U, Beregi JP et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008;358:689-99. (Pubitemid 351240748)
44. Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 2008;118:1358-65.
45. Micari A. Drug eluting balloon for the treatment of femoropopliteal arterial disease mid-term results from a multicenter Italian registry. EuroPCR 2010.
46. Werk M. The Pacifier Trial - A Randomized Multicenter Trial Evaluating Prevention of Restenosis with Paclitaxel-Coated PTA Balloon Catheters in Stenosis or Occlusion of Femoropopliteal Arteries. CIRSE 2011.
47. Karnabatidis D. DEB in AV fistulas: Results from a randomized trial. CIRSE 2011.
48. Schmidt A, Piorkowski M, Werner M, Ulrich M, Bausback Y, Bräunlich S et al. First experience with drug-eluting balloons in infrapopliteal arteries restenosis rate and clinical outcome. J Am Coll Cardiol 2011;58:1105-9.
49. Liistro F. Drug eluting balloon for below the knee angioplasty evaluation: The DEBATE-BTK study. UNC 2011.
50. Biondi-Zoccai G, Sangiorgi G, Modena MG. Devices for infrainguinal endovascular therapy: menu à la carte or table d'hôte? J Endovasc Ther 2011;18:638-41.
51. Kudo T, Chandra FA, Ahn SS. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience. J Vasc Surg 2005;41:423-35. (Pubitemid 40523584)
52. Armstrong DG, Boulton AJ, Andros G, Attinger C, Eisenbud D, Lavery LA et al. Defining success in clinical trials of diabetic foot wounds: the Los Angeles DFCon consensus. Int Wound J 2009;6:211-3.
53. Söderström M, Arvela E, Albäck A, Aho PS, Lepäntalo M. Healing of ischaemic tissue lesions after infrainguinal bypass surgery for critical leg ischaemia. Eur J Vasc Endovasc Surg 2008;36:90-5. (Pubitemid 351876154)
54. Randon C, Jacobs B, De Ryck F, Beele H, Vermassen F. Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage. J Vasc Surg 2010;51:869-77.
55. Iida O, Nanto S, Uematsu M, Ikeoka K, Okamoto S, Dohi T et al. Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia. Catheter Cardiovasc Interv 2010;75:830-6.
56. Neville RF, Attinger CE, Bulan EJ, Ducic I, Thomassen M, Sidawy AN. Revascularization of a specific angiosome for limb salvage: does the target artery matter? Ann Vasc Surg 2009;23:367-73
57. Ferraresi R, Palloshi A, Aprigliano G, Caravaggi C, Centola M, Sozzi F et al. Angioplasty of below-the-elbow arteries in critical hand ischaemia. Eur J Vasc Endovasc Surg 2012;43:73-80.
58. Ferraresi R, Ferlini M, Sozzi F, Pomidossi G, Caravaggi C, Danzi GB. Images in cardiovascular medicine. Percutaneous transluminal angioplasty for treatment of critical hand ischemia. Circulation 2006;114:e232-4. (Pubitemid 44199630)
59. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF et al.; BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005;366:1925-34. (Pubitemid 41713982)
60. Gouëffic Y, Biondi-Zoccai G. Drug coated balloon: technical specificities. In: Endovascular below the knee revascularization combo. Divine ID, Marseille: 2011.